In addition, IL-32 is substantially co-localized with pro-inflammatory cytokines (TNF, IL-1β, IL-6) in inflamed tissues in the context of inflammatory bowel disease, in synovial tissues from rheumatoid arthritis or serum from psoriasis patients (9). The gene discussed is IL32; the disease is inflammatory bowel disease.